HIV gp160 Env expression of

Ad-HIV showed MVA-GFP-dose dependent decrease in the A549 cells co-infected with Ad-HIV and MVA-GFP (Fig. 3a, left panel). However, the difference of the HIV gp160 Env expression was not observed in the cells co-infected with MVA-HIV and Ad-GFP (Fig. 3a, right panel). Furthermore, we co-infected A549 cells with Ad-SEAP (100 and 1000 vp/cell) and MVA-GFP (from 0.1 to 10 pfu/cell). SEAP activity in the cell supernatant was detected 48 h after the viral infection (Fig. 3b). In comparison to Ad-SEAP alone, co-infection with 1000 vp/cell of Ad-SEAP and MVA-GFP at a dose of 0.1, 1, or 10 pfu/cell decreased SEAP activity by 26%, 48%, or 88%, respectively (Fig. 3b). Likewise, co-infection with 100 vp/cell of Ad-SEAP and MVA-GFP at a dose of 0.1, check details 1, or 10 pfu/cell decreased SEAP activity by 16%, 33%, and 67%, respectively. To explore whether the SEAP suppression induced by MVA was from a viral infection-related factor, we infected Ad-SEAP at a dose of 1000 vp/cell with 10% of the cell supernatant

harvested from either non-MVA-infected or 6- to 72-h MVA-infected cells. SEAP activity was significantly inhibited when the Ad-SEAP-infected A549 cells were incubated with the 24-, 48-, and 72-h MVA-infected cell supernatant (Fig. 3c), as compared to the non-infected cell supernatant. These results suggest that interference was mediated via Akt inhibitor soluble factor(s) secreted by viral infected cells. To investigate whether viral interference resulted from diverse viruses expressed in the same cells, we infected Ad-Cherry and MVA-GFP into A549 cells. As shown in Fig. 3d, no dual viral infection was observed when the A549 cells were co-infected with either 10,000 vp/cell of Ad-Cherry and 1 pfu/cell of MVA-GFP, or infected with 100 vp/cell of Ad-Cherry and 10 pfu/cell of MVA-GFP. Virus infection induces type I interferon (in all kinds of cells) and type II interferon (in dendritic cells and macrophages). To explore whether science the interferon cytokines included the soluble factor(s), we detected the mRNA of type I interferon (IFNα, IFNβ) and type II interferon (IFNγ)

in Ad- or MVA-infected A549 cells at various time points between 0 and 96 h post infection. As shown in Fig. 4a, the mRNA of IFNα and IFNγ was not detected at any point of time, and only a small amount of IFNβ was detected after 40 cycles of PCR. Furthermore, the level of IFNβ protein was under its respective detection limit as per human IFNβ ELISA (minimum, 100 pg/ml; data not shown). In the final experiment, we explored whether a human IFNβ-neutralizing antibody could block the suppression of Ad-SEAP expression by the MVA supernatant. The supernatant from the 48-h MVA-infected A549 and anti-human IFNβ-neutralizing antibody or control mouse IgG was premixed with Ad-SEAP (1000 vp/cell) followed by infection of the A549 cells. The SEAP activity was detected at 48 h post infection. As shown in Fig.